TR200101401T2 - Kaplanmış ilaç parçacıkları hazırlamak, bunların ispençiyari formulasyonu için metod - Google Patents

Kaplanmış ilaç parçacıkları hazırlamak, bunların ispençiyari formulasyonu için metod

Info

Publication number
TR200101401T2
TR200101401T2 TR2001/01401T TR200101401T TR200101401T2 TR 200101401 T2 TR200101401 T2 TR 200101401T2 TR 2001/01401 T TR2001/01401 T TR 2001/01401T TR 200101401 T TR200101401 T TR 200101401T TR 200101401 T2 TR200101401 T2 TR 200101401T2
Authority
TR
Turkey
Prior art keywords
coated drug
drug particles
particles
preparation
pharmaceutical formulations
Prior art date
Application number
TR2001/01401T
Other languages
English (en)
Inventor
D. Talton James
Hochhaus Guenther
K. Singh Rajiv
M. Fitz-Gerald James
Original Assignee
University Of Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Florida filed Critical University Of Florida
Publication of TR200101401T2 publication Critical patent/TR200101401T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C14/00—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material
    • C23C14/22—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the process of coating
    • C23C14/223—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the process of coating specially adapted for coating particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C14/00—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material
    • C23C14/22—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the process of coating
    • C23C14/24—Vacuum evaporation
    • C23C14/28—Vacuum evaporation by wave energy or particle radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mechanical Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Metallurgy (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Üniform bir ebada ve kalinliga sahip olan kaplanmis ilaç partiküllerinin hazirlanmasi için palsli lazerle ablasyon kullanilan metodlar tarif edilmektedir.Kaplanmis ilaç partiküllerinin ebadi çap olarak birkaç nanometre ila birkaç milimetre mertebesindedir ve bunlar ortalama çaplari yaklasik 1 ila 50 nm olan organik polimer partikülleri ile kaplanir.Gösterme gayesi ile verilen tecessümlerde,kaplanmis ilaç partikülleri ya da ,ilaç uygulama partikülleri tarif edilmekte , ve bunlar kontrollu bir uygulama ve artan bir biyoelverislilik için üstün farmasötik özellikler sergileyen , ve kontrollu bir kalinliga ve kontrollu bir kaplama üniformitesine sahip olan, biyodegrasyona ugrayan ya d biyo-uyumlu olan bir polimer kaplama içermektedir.
TR2001/01401T 1998-11-18 1999-11-18 Kaplanmış ilaç parçacıkları hazırlamak, bunların ispençiyari formulasyonu için metod TR200101401T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10884798P 1998-11-18 1998-11-18
US11029198P 1998-11-30 1998-11-30

Publications (1)

Publication Number Publication Date
TR200101401T2 true TR200101401T2 (tr) 2001-11-21

Family

ID=26806343

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/01401T TR200101401T2 (tr) 1998-11-18 1999-11-18 Kaplanmış ilaç parçacıkları hazırlamak, bunların ispençiyari formulasyonu için metod

Country Status (19)

Country Link
EP (1) EP1131054B1 (tr)
JP (1) JP2003516926A (tr)
KR (1) KR20010082309A (tr)
CN (1) CN1200693C (tr)
AT (1) ATE317687T1 (tr)
AU (1) AU757121B2 (tr)
BR (1) BR9915462A (tr)
CA (1) CA2350894C (tr)
CZ (1) CZ300323B6 (tr)
DE (1) DE69929904T2 (tr)
ES (1) ES2257881T3 (tr)
HK (1) HK1043548B (tr)
HU (1) HUP0104687A3 (tr)
IL (2) IL143234A0 (tr)
NO (1) NO20012395L (tr)
NZ (1) NZ511689A (tr)
PL (1) PL349953A1 (tr)
TR (1) TR200101401T2 (tr)
WO (1) WO2000028969A2 (tr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984404B1 (en) 1998-11-18 2006-01-10 University Of Florida Research Foundation, Inc. Methods for preparing coated drug particles and pharmaceutical formulations thereof
US6406745B1 (en) 1999-06-07 2002-06-18 Nanosphere, Inc. Methods for coating particles and particles produced thereby
RU2250764C2 (ru) * 1999-06-07 2005-04-27 Наносфер, Инк. Способ нанесения покрытий на частицы и частицы, полученные этим способом
AU2005201757B2 (en) * 1999-06-07 2007-04-26 Nanotherapeutics, Inc. Methods for coating particles and particles produced thereby
AU2001263242A1 (en) 2000-05-19 2001-12-03 Ppg Industries Ohio, Inc. Coating compositions having a geometrically ordered array of polymeric particlesand substrates coated therewith
ES2689704T3 (es) 2000-11-30 2018-11-15 Vectura Limited Partículas para usar en una composición farmacéutica
ATE517607T1 (de) 2000-11-30 2011-08-15 Vectura Ltd Verfahren zur herstellung von partikeln zur verwendung in einer pharmazeutischen zusammensetzung
JP2004516262A (ja) * 2000-12-21 2004-06-03 ネクター セラピューティクス 親水性活性剤を含有するマイクロ粒子の製造のための誘発相転移法
JP2003342196A (ja) * 2002-05-31 2003-12-03 Mukku:Kk 静脈注射用組成物、その製造法およびその製剤
SG151103A1 (en) * 2002-08-27 2009-04-30 Hiroshi Terada Remedy
ATE371436T1 (de) 2003-05-19 2007-09-15 Euro Celtique Sa Trockene liposomale pvp-jod zubereitungen
JPWO2004110405A1 (ja) * 2003-06-11 2006-08-17 株式会社奈良機械製作所 薬物ナノ粒子、その粒子を使用した薬剤の製造方法および薬剤の製造装置
JP2006218346A (ja) * 2005-02-08 2006-08-24 Honda Motor Co Ltd 水素吸着材及びその製造方法
ES2643938T3 (es) * 2007-03-30 2017-11-27 Otsuka Pharmaceutical Co., Ltd. Liposoma transpulmonar para controlar la llegada del fármaco
US20090004231A1 (en) 2007-06-30 2009-01-01 Popp Shane M Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
EP2211841A4 (en) * 2007-10-15 2013-03-13 Cooperative Res Ct For Asthma PROPHYLAXIS METHOD AND AGENTS FOR USE IN THIS METHOD
EP2279283A1 (de) * 2008-03-27 2011-02-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zur herstellung eines mehrkomponentigen, polymer- und metallhaltigen schichtsystems, vorrichtung und beschichteter gegenstand
WO2009131537A1 (en) * 2008-04-25 2009-10-29 Karolinska Institutet Innovations Ab New therapy of treatment of the irritable bowel syndrome.
GB0814302D0 (en) 2008-08-05 2008-10-01 Coretherapix Slu Compounds and methods
US8409619B2 (en) 2008-10-15 2013-04-02 Lifecare Innovations Pvt. Ltd. Oral drug delivery system for azole, moxifloxacin and rifampicin
WO2010058840A1 (ja) * 2008-11-20 2010-05-27 テルモ株式会社 リポソームからの薬物放出手段および放出性評価法
SE535381C2 (sv) * 2010-02-24 2012-07-17 Plasmadvance Ab Plasmasputtringsprocess för att producera partiklar
CA2851566C (en) * 2011-10-14 2020-01-14 Dsm Ip Assets B.V. Novel coating system
JP6334214B2 (ja) * 2013-03-08 2018-05-30 学校法人慶應義塾 レーザーを用いた薬剤放出方法
CA3136305A1 (en) 2019-04-08 2020-10-15 R.P. Scherer Technologies, Llc Analytical method for determining the total amount of a coating polymer in a dosage form
IL295268A (en) * 2020-02-19 2022-10-01 Nano Pharmasolutions Inc Therapeutic material nanoparticles and methods for preparation
WO2024211814A1 (en) * 2023-04-06 2024-10-10 Applied Materials, Inc. Pharmaceutical compositions with improved dissolution

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200669A (en) * 1978-11-22 1980-04-29 The United States Of America As Represented By The Secretary Of The Navy Laser spraying
US4623588A (en) * 1984-02-06 1986-11-18 Biotek, Inc. Controlled release composite core coated microparticles
DE3541999A1 (de) * 1985-11-28 1987-06-04 Bbc Brown Boveri & Cie Verfahren und vorrichtung zur beschichtung von flaechen
WO1990002546A1 (en) * 1988-09-09 1990-03-22 The Ronald T. Dodge Company Pharmaceuticals microencapsulated by vapor deposited polymers and method
DE4239244A1 (de) * 1992-11-21 1994-05-26 Basf Ag Retard-Form für pharmazeutische Wirkstoffe
US6025036A (en) * 1997-05-28 2000-02-15 The United States Of America As Represented By The Secretary Of The Navy Method of producing a film coating by matrix assisted pulsed laser deposition
WO1999047726A1 (en) * 1998-03-19 1999-09-23 The University Of Florida Process for depositing atomic to nanometer particle coatings on host particles

Also Published As

Publication number Publication date
CA2350894C (en) 2009-01-27
EP1131054B1 (en) 2006-02-15
AU2345700A (en) 2000-06-05
CN1200693C (zh) 2005-05-11
ES2257881T3 (es) 2006-08-01
NZ511689A (en) 2003-03-28
IL143234A (en) 2007-05-15
KR20010082309A (ko) 2001-08-29
AU757121B2 (en) 2003-02-06
WO2000028969A2 (en) 2000-05-25
NO20012395L (no) 2001-07-16
PL349953A1 (en) 2002-10-21
ATE317687T1 (de) 2006-03-15
DE69929904D1 (de) 2006-04-20
BR9915462A (pt) 2001-12-11
EP1131054A2 (en) 2001-09-12
NO20012395D0 (no) 2001-05-15
HUP0104687A2 (en) 2002-06-29
DE69929904T2 (de) 2006-08-31
CZ300323B6 (cs) 2009-04-22
CN1348361A (zh) 2002-05-08
HK1043548B (zh) 2006-01-06
CZ20011747A3 (cs) 2001-10-17
WO2000028969A3 (en) 2000-11-09
IL143234A0 (en) 2002-04-21
HK1043548A1 (en) 2002-09-20
HUP0104687A3 (en) 2006-07-28
JP2003516926A (ja) 2003-05-20
CA2350894A1 (en) 2000-05-25

Similar Documents

Publication Publication Date Title
TR200101401T2 (tr) Kaplanmış ilaç parçacıkları hazırlamak, bunların ispençiyari formulasyonu için metod
Jagur-Grodzinski Biomedical application of functional polymers
Fathollahipour et al. Electrospinning of PVA/chitosan nanocomposite nanofibers containing gelatin nanoparticles as a dual drug delivery system
Dash et al. Poly-є-caprolactone based formulations for drug delivery and tissue engineering: A review
IT1243390B (it) Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
Kaur et al. The benefits of macromolecular/supramolecular approaches in hydrogen sulfide delivery: a review of polymeric and self-assembled hydrogen sulfide donors
US9198875B2 (en) Controlled delivery of bioactive agents from decomposable films
Kumar et al. In-vitro and in-vivo study of indomethacin loaded gelatin nanoparticles
Ribeiro et al. Advances in Hybrid Polymer‐Based Materials for Sustained Drug Release
Deshmukh et al. Functionalized nanosponges for controlled antibacterial and antihypocalcemic actions
KR20070120158A (ko) 다공성 소결 금속 물질의 제조 방법
Blanco et al. Chitosan microspheres in PLG films as devices for cytarabine release
JP2007514518A (ja) 水素結合によって結合した多層中性ポリマーフィルムのカプセル
Athar et al. Cellulose nanocrystals and PEO/PET hydrogel material in biotechnology and biomedicine: current status and future prospects
Liu et al. Electrospun poly (L-lactic acid)/gelatine membranes loaded with doxorubicin for effective suppression of glioblastoma cell growth in vitro and in vivo
Yousefi et al. Polycaprolactone/chitosan core/shell nanofibrous mat fabricated by electrospinning process as carrier for rosuvastatin drug
Yang et al. Doxorubicin‐loaded poly (butylcyanoacrylate) nanoparticles produced by emulsifier‐free emulsion polymerization
Yoha et al. Surface modification of bio-polymeric nanoparticles and its applications
Polacco et al. Biodegradable hollow fibres containing drug‐loaded nanoparticles as controlled release systems
Samy et al. In vitro release study of electrospun poly (ε-caprolactone)/gelatin nanofiber mats loaded with 5-fluorouracil
Szczesna et al. Szyk-Warszy nska, L.; Zboi nska, E.; Warszy nski, P.; Wilk, KA Multilayered curcumin-loaded hydrogel microcarriers with antimicrobial function
Saharan et al. Beyond traditional hydrogels: The emergence of graphene oxide-based hydrogels in drug delivery
WO2005079856A1 (en) Drug delivery compositions comprising hydrophobic polymers and amphipathic molecules
Ouchi et al. Formation of polymeric micelles with amino surfaces from amphiphilic AB‐type diblock copolymers composed of poly (glycolic acid lysine) segments and polylactide segments
Sarkar et al. Development and in-vitro characterisation of chitosan loaded paclitaxel nanoparticle